News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Press Releases
Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)
July 25, 2024
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)
Attachment
2024 Ipsen Half-Year Financial Report
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
January 15, 2025
·
4 min read
·
Tristan Manalac
Earnings
Lilly Projects 2024 Revenue Miss as Zepbound, Mounjaro Disappoint
January 14, 2025
·
2 min read
·
Dan Samorodnitsky
Cancer
Where Keytruda Failed, Regeneron Touts Phase III Skin Cancer Win for Libtayo
January 14, 2025
·
2 min read
·
Tristan Manalac
Earnings
Sarepta Previews Q4 Findings, Touts Elevidys Earnings Beat
January 14, 2025
·
2 min read
·
Tristan Manalac
